The Infusion Blog: Perspectives from the INside

Blog articles are primarily written by voices of the infusion industry. The opinions of guest authors do not necessarily represent or reflect the opinions or positions of NICA. 

You have just been diagnosed with a complex, chronic disease… now what? It is normal to feel a lot of anxiety and uncertainty with a new diagnosis. With one big answer can come a plethora of questions. We talked to Lupus warrior and inspirational fitness trainer, Sybella Davis, on what advice she would lend those who have recently been diagnosed and are wondering what steps to take next. Sybella was diagnosed with Lupus in February
The following post is written by Sumaira Ahmed, matriarch of The Sumaira Foundation, a 501(c)(3) organization dedicated to generating global awareness of neuromyelitis optica spectrum disorder (NMOSD), fundraising to help find a cure, and creating a community of support for patients and their caregivers.      I used to be the kind of person who refused Tylenol because I didn’t like the idea of having medications floating around in my body. I had just turned
From the Broomstick of Julie Baak  This is the 3rd grade math explanation of how Pharmacy Benefit Managers (PBMs) work: PBM denies $300 drug. They then force the doctor to use the $1200 version made by the same company with a different label, and makes the price $1194. And then, BlueCross BlueShield of Tennessee (BCBST), for example, just saved the patient $6 whole dollars.  Follow the money, it always tells the real story.  This is the
Tags: ,
The following article is written by Marketing and Communications Coordinator, Cristina Threlkeld for the National Infusion Center Association. Patients rely on easy and affordable access to their medications. Prescribing clinicians and sites of treatment also rely on accessibility and the flexibility to obtain these medications in the most cost-effective and seamless way possible. In 2020, BlueCross BlueShield of Tennessee (BCBST) enacted a specialty pharmacy mandate (i.e., mandatory white-bagging) requiring that the doctors of some of
Infusions Instead of Back Surgery by Steven Baak, MD My neighbor was walking slowly to his mailbox.  I walked over and asked, “What happened to you?” “I’m going in for back surgery on Wednesday. I waited six months to get this scheduled with the best surgeon in the Midwest,” he said.  “What surgery are you getting?” I asked him. “Oh, well, it’s super complicated, my MRIs are a mess, the surgeon is going to cut
Written by Andrew Donovan Managing life during this COVID-19 pandemic is quite different than it was just a few short weeks ago. Many of us have experienced social isolation, shelter in place, or stay at home orders. Others may have experienced postponement or cancellation of scheduled procedures or appointments as healthcare organizations work to increase their capacity to care for patients in the event of a COVID-19 surge. For those living with the daily impact
From the Broomstick of Julie Baak Pharmacy Benefit Managers (PBM) are the middlemen that do none of the work and make most of the money. Fun Fact: PBMs have their MBAs tell MDs which drugs (formulary) they can prescribe based on how much money the PBM can make instead of clinical efficiency and the welfare of the patient(s). These ‘formularies’ are created based on drug manufacturers paying bribes and kickbacks in the forms of rebates, fees, and/or discounts in exchange for